Randomized clinical trial demonstrates significant improvements in walking ability for patients receiving therapy with the ReStore Exo-Suit as compared to a matched[...]
Lifeward brand reflects the Company’s commitment to pioneering innovative technology to empower the pursuit of life’s ambitions in the face of physical[...]
ReWalk Personal Exoskeleton covered as a medically necessary device for an eligible Medicare beneficiary with spinal cord injury MARLBOROUGH, MA, BERLIN, Germany,[...]
R&D Grant from the Israeli Technology Innovation Consortium Enabled the Successful Demonstration of a Working Prototype MARLBOROUGH, Mass. and BERLIN and YOKNEAM[...]
Veterans STAND Act mandates regular evaluations of paralyzed Veterans and proactively identifies clinically-eligible Veterans for expedited procurement of personal exoskeletons. MARLBOROUGH, MA,[...]
MARLBOROUGH, MA, BERLIN, Germany and YOKNEAM ILLIT, Israel, November 6, 2023 – ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the “Company”), a[...]
2024 Medicare Home Health Rule finalizes Medicare benefit category for personal exoskeletons.
Recently ReWalk Robotics™ announced the acquisition of AlterG® Inc., a global industry leader in innovative rehabilitation technology and the makers of the[...]
Combined Company Expands Patient and Clinician Access to Innovative Rehabilitation Technologies for Home and Clinic Use Transaction Projected to Increase Revenue Growth[...]
